Translate
Pharmacovigilance Agreement Solutions You Didn’t Realize You Needed
Event Date: Thursday, 16 May 2024
Event Time: 10:00 to 11:00 a.m. EST
Join us for an overview of TransCelerate’s Pharmacovigilance Agreements Optimization (PVAO) Initiative, which includes a suite of solutions designed to help organizations enhance their PVA process. These solutions can help organizations improve their processes and potentially achieve more efficient negotiations with business partners globally.
The webinar will include:
- An overview of the Pharmacovigilance Agreements Optimization (PVAO) Initiative that could be used to inform and/or help streamline the end-to-end PVA process.
- A deeper dive into the two most recent solutions:
- Timelines Benchmarking: Aggregate benchmarking data on exchange timelines.
- Audit Process Efficiencies: Suite of solutions providing marketing partner audit considerations.
- Q&A will address audience questions on the PVAO solution
Panelists:
- Yvonne Gibble, Executive Director Pharmacovigilance Licensing & Business Development, Merck Sharpe & Dohme, LLC
- Beth MacEntee Pileggi, Head of Global Case and Safety Data Management, J&J
- Wendy Manko Singer, Individual Case Medical Review, Global Clinical Safety & Pharmacovigilance, Merck Sharpe & Dohme, LLC
- Jonathan Rowell, Senior Director, Head of Pharmacovigilance QA, J&J
Ideal Attendees:
- Managers
- Alliance Managers
- Safety Scientists
- Pharmacovigilance Managers, Officers, Associates, Specialists, Directors
- Pharmacovigilance Licensing
- Pharmacovigilance Alliances, Experts, Leads
- Safety Data Exchange Agreement Managers, Officers, Associates, Specialists, Directors
- Patient Safety Directors, Managers, Officers, Associates, Specialists
- Global and Local Patient Safety
- Pharmacovigilance Country Head(s)
- QPPV
- Local QPPV
- Business Development and Licensing (BD&L) Directors, Associate Directors, Managers
TransCelerate webinars may be recorded in whole or in part.